Summit Securities Group’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-40
Closed -$9K 329
2013
Q2
$9K Buy
+40
New +$9K ﹤0.01% 268